Dr Mouhssin Oufir

Oncodesign is a French biopharmaceutical company developing new candidates in targeting kinases in oncology and other therapeutic areas (Inflammation, immunology, neurodegenerative diseases & infectious diseases).
We propose our 24 years of Research and Development expertise in small molecules for any company to outsource new drug candidate generation by providing an Integrated Drug Discovery Service as a package or on a fee for service basis including:
• Medicinal Chemistry
• Pharmacology
• DMPK
• Bio-analysis integrated services (GPx environment)
• Protein characterization
• Safety and Toxicity
Oncodesign is based in Dijon, France, in the heart of the town’s university and hospital hub, and within the Paris-Saclay cluster.
Oncodesign has 230 employees and subsidiaries in Canada and the USA.